OncLive interviews Jennifer A. Woyach, MD, on the current research and treatment spectrum for chronic lymphocytic leukemia (CLL). Dr. Woyach, an investigator with The James Ohio State University Comprehensive Cancer Center, is a nationally recognized CLL expert and dedicated to finding cures. She has ranked in the top 10% nationwide for patient satisfaction
She is an oncologist treating patients with blood cancers. Dr. Woyach specializes in chronic lymphocytic leukemia (CLL) and b-cell lymphomas. She also serves as an associate professor in Ohio State’s division of hematology. Their approach to patient care is what they believe to be unique at OSUCCC—James. Why? They work in teams of specialists, subspecialists and super subspecialists to better treat cancers, while never forgetting the power and value of personalized, patient-centered care. According to their website, Dr. Woyach was rated in the top 10% of physicians in the nation for patient satisfaction.
Her research focuses on CLL and other blood cancers. She conducts laboratory research and lead clinical trials to develop novel therapies for patients with these conditions. She is particularly interested in targeted therapies for CLL and working to figure out ways to overcome resistance to targeted therapies. Dr. Woyach is driving to find cures.
Follow the link below to review in depth Dr. Woyach’s perspective on the state of current CLL investigational treatments in the pipeline.